IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q1 FY22 results · Apr–Jun 2021
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹518.51 crore (up 12.7% from Q1 FY21) and net profit of ₹67.00 crore (down 47.5% from Q1 FY21) for Q1 FY22 (Apr–Jun 2021), on a standalone basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 518.51 | 460.11 | +12.7% | 460.38 | +12.6% |
| Other income | 5.72 | 5.80 | −1.4% | 6.21 | −7.9% |
| Total income | 524.23 | 465.91 | +12.5% | 466.59 | +12.4% |
| Profit before tax | 89.85 | 146.74 | −38.8% | 105.97 | −15.2% |
| Net profit for the period | 67.00 | 127.54 | −47.5% | 75.25 | −11.0% |
| EPS, basic (₹) | 11.41 | 22.30 | −48.8% | 12.76 | −10.6% |
| Net margin (%) | 12.9 | 27.7 | 16.3 |
Standalone
- Filed with BSE
- 13 Aug 2021, 20:13 IST
- Board meeting
- 13 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Audited
- Source
- XBRL filing on BSE